Abstract
Estrogen plays several important physiological and pathological functions in not only reproductive system but many other systems as well. Its transcriptional activation has been traditionally described as being mediated by classic nuclear estrogen receptors (ERs). It is however established recently that a novel functional estrogen transmembrane receptor, G protein-coupled receptor 30 (GPR30), modulates both rapid non-genomic events and genomic transcriptional events of estrogen. It has been demonstrated that GPR30 promotes the progress of estrogen-related tumors through mitogen-activated protein kinase (MAPK) signaling pathways. Effects mediated by GPR30 are maintained when classic ERs are absent or blocked. In addition, GPR30 is involved in drug resistance, which is often occurring during cancer treatments. All these new findings strongly imply that GPR30 may be an important therapeutic target for estrogen-related tumors. Simultaneously blocking both GPR30 and classic ERs may be a better strategy for the treatment of estrogen-related tumors.
Similar content being viewed by others
References
G.R. Frank, Med. Pediatr. Oncol. 41, 217–221 (2003)
L. Baker, K.K. Meldrum, M. Wang et al., J. Surg. Res. 115, 325–344 (2003)
C.D. Toran-Allerand, Endocrinology 145, 1069–1074 (2004)
E.J. Kovacs, K.A. Messingham, M.S. Gregory, Mol. Cell. Endocrinol. 193, 129–135 (2002)
E.V. Jensen, E.R. DeSombre, Science 182, 126–134 (1973)
G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, J.A. Gustafsson, Proc Natl Acad Sci USA 93, 5925–5930 (1996)
J.M. Hall, J.F. Couse, K.S. Korach, J. Biol. Chem. 276, 36869–36872 (2001)
G.G. Kuiper, B. Carlsson, K. Grandien et al., Endocrinology 138, 863–870 (1997)
K. Dechering, C. Boersma, S. Mosselman, Curr. Med. Chem. 7, 561–576 (2000)
G.G. Chen, Q. Zeng, G.M. Tse, Med. Res. Rev. 28, 954–974 (2008)
A. Strom, J. Hartman, J.S. Foster et al., Proc. Natl. Acad. Sci. USA 101, 1566–1571 (2004)
L.A. Helguero, M.H. Faulds, J.A. Gustafsson, L.A. Haldosen, Oncogene 24, 6605–6616 (2005)
Z. Weihua, S. Saji, S. Makinen et al., Proc. Natl. Acad. Sci. USA 97, 5936–5941 (2000)
W.A. Ricke, S.J. McPherson, J.J. Bianco et al., FASEB J. 22, 1512–1520 (2008)
J. Cheng, E.J. Lee, L.D. Madison, G. Lazennec, FEBS Lett. 566, 169–172 (2004)
Q. Zeng, G.G. Chen, A.C. Vlantis, C.A. van Hasselt, Cell Prolif. 40, 921–935 (2007)
E.R. Prossnitz, L.A. Sklar, T.I. Oprea, J.B. Arterburn, Trends Pharmacol. Sci. 29, 116–123 (2008)
E.R. Prossnitz, J.B. Arterburn, L.A. Sklar, Mol. Cell. Endocrinol. 265–266, 138–142 (2007)
E.J. Filardo, J.A. Quinn, A.R. Frackelton Jr., K.I. Bland, Mol. Endocrinol. 16, 70–84 (2002)
P. Thomas, Y. Pang, E.J. Filardo, J. Dong, Endocrinology 146, 624–632 (2005)
L. Albanito, A. Madeo, R. Lappano et al., Cancer Res. 67, 1859–1866 (2007)
E.R. Prossnitz, T.I. Oprea, L.A. Sklar, J.B. Arterburn, J Steroid Biochem. Mol. Biol. 109, 350–353 (2008)
M. Maggiolini, A. Vivacqua, G. Fasanella et al., J. Biol. Chem. 279, 27008–27016 (2004)
Y. Takada, C. Kato, S. Kondo, R. Korenaga, J. Ando, Biochem. Biophys. Res. Commun. 240, 737–741 (1997)
C. Owman, P. Blay, C. Nilsson, S.J. Lolait, Biochem. Biophys. Res. Commun. 228, 285–292 (1996)
C. Carmeci, D.A. Thompson, H.Z. Ring, U. Francke, R.J. Weigel, Genomics 45, 607–617 (1997)
B.F. O’Dowd, T. Nguyen, A. Marchese et al., Genomics 47, 310–313 (1998)
E.J. Filardo, J.A. Quinn, K.I. Bland, A.R. Frackelton Jr., Mol. Endocrinol. 14, 1649–1660 (2000)
Y.Y. He, B. Cai, Y.X. Yang, X.L. Liu, X.P. Wan, Cancer Sci. 100(6), 1051–1061 (2009)
E.J. Filardo, C.T. Graeber, J.A. Quinn et al., Clin. Cancer Res. 12, 6359–6366 (2006)
Z. Zhang, L. Duan, X. Du et al., Prostate 68, 508–516 (2008)
E. Haas, M.R. Meyer, U. Schurr et al., Hypertension 49, 1358–1363 (2007)
E.R. Hugo, T.D. Brandebourg, J.G. Woo et al., Environ. Health Perspect. 116, 1642–1647 (2008)
L. Albanito, D. Sisci, S. Aquila et al., Endocrinology 149, 3799–3808 (2008)
C. Wang, E.R. Prossnitz, S.K. Roy, Endocrinology 148, 4853–4864 (2007)
F. Gobeil, A. Fortier, T. Zhu et al., Can. J. Physiol. Pharmacol. 84, 287–297 (2006)
T. Funakoshi, A. Yanai, K. Shinoda, M.M. Kawano, Y. Mizukami, Biochem. Biophys. Res. Commun. 346, 904–910 (2006)
E. Filardo, J. Quinn, Y. Pang et al., Endocrinology 148, 3236–3245 (2007)
C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, E.R. Prossnitz, Science 307, 1625–1630 (2005)
C.M. Revankar, H.D. Mitchell, A.S. Field et al., ACS Chem. Biol. 2, 536–544 (2007)
C. Wang, E.R. Prossnitz, S.K. Roy, Endocrinology 149, 4452–4461 (2008)
K. Matsuda, H. Sakamoto, H. Mori et al., Neurosci. Lett. 441, 94–99 (2008)
C. Otto, B. Rohde-Schulz, G. Schwarz et al., Endocrinology 149, 4846–4856 (2008)
C.G. Bologa, C.M. Revankar, S.M. Young et al., Nat. Chem. Biol. 2, 207–212 (2006)
A. Vivacqua, D. Bonofiglio, A.G. Recchia et al., Mol. Endocrinol. 20, 631–646 (2006)
A. Vivacqua, D. Bonofiglio, L. Albanito et al., Mol. Pharmacol. 70, 1414–1423 (2006)
D.P. Pandey, R. Lappano, L. Albanito et al., EMBO J. 28, 523–532 (2009)
P. Thomas, J. Dong, J. Steroid Biochem. Mol. Biol. 102, 175–179 (2006)
K. Leblanc, E. Sexton, S. Parent et al., Int. J. Oncol. 30, 477–487 (2007)
R.E. Muller, T.C. Johnston, A.M. Traish, H.H. Wotiz, Adv. Exp. Med. Biol. 117, 401–421 (1979)
G.M. Dick, A.C. Hunter, K.M. Sanders, Mol. Pharmacol. 61, 1105–1113 (2002)
C. Hermenegildo, A. Cano, Hum. Reprod. Update 6, 237–243 (2000)
I. Vivanco, C.L. Sawyers, Nat. Rev. Cancer 2, 489–501 (2002)
G. Posern, R. Treisman, Trends Cell Biol. 16, 588–596 (2006)
A. Gutierrez-Hartmann, D.L. Duval, A.P. Bradford, Trends Endocrinol. Metab. 18, 150–158 (2007)
W.H. Kuo, L.Y. Chang, D.L. Liu et al., Taiwan J. Obstet. Gynecol. 46, 135–145 (2007)
E.J. Filardo, J Steroid Biochem. Mol. Biol. 80, 231–238 (2002)
E.J. Filardo, J.A. Quinn, E. Sabo, Steroids 73, 870–873 (2008)
H.O. Smith, K.K. Leslie, M. Singh et al. Am. J. Obstet. Gynecol. 196, 386 e381–389; discussion 386 e389–311 (2007)
E. Henic, V. Noskova, G. Hoyer-Hansen, S. Hansson, B. Casslen, Int. J. Gynecol. Cancer 19, 214–222 (2009)
L. Albanito, R. Lappano, A. Madeo et al., Environ. Health Perspect. 116, 1648–1655 (2008)
R.A. Alyea, S.E. Laurence, S.H. Kim et al., J. Neurochem. 106, 1525–1533 (2008)
Z. Liu, X. Yu, Z.A. Shaikh, Toxicol. Appl. Pharmacol. 228, 286–294 (2008)
K. Kang, S.B. Lee, S.H. Jung et al., Mol. Cells 27, 351–357 (2009)
B. Kleuser, D. Malek, R. Gust, H.H. Pertz, H. Potteck, Mol. Pharmacol. 74, 1533–1543 (2008)
E.W. Lapensee, T.R. Tuttle, S.R. Fox, N. Ben-Jonathan, Environ. Health Perspect. 117, 175–180 (2009)
L.I. Gold, Crit. Rev. Oncog. 10, 303–360 (1999)
G.I. Evan, K.H. Vousden, Nature 411, 342–348 (2001)
A.J. Ridley, M.A. Schwartz, K. Burridge et al., Science 302, 1704–1709 (2003)
D. Hanahan, R.A. Weinberg, Cell 100, 57–70 (2000)
M.B. Sporn, Lancet 347, 1377–1381 (1996)
P.L. Fitzgibbons, D.L. Page, D. Weaver et al., Arch. Pathol. Lab. Med. 124, 966–978 (2000)
D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, CA Cancer J. Clin. 55, 74–108 (2005)
B. Hanstein, S. Djahansouzi, P. Dall, M.W. Beckmann, H.G. Bender, Eur. J. Endocrinol. 150, 243–255 (2004)
S. Ali, R.C. Coombes, J Mammary Gland Biol. Neoplasia 5, 271–281 (2000)
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Lancet 365, 1687–1717 (2005)
O. Treeck, B. Wackwitz, U. Haus, O. Ortmann, Gynecol. Oncol. 102, 292–299 (2006)
J.Z. Yang, C. O’Flatharta, B.J. Harvey, W. Thomas, Steroids 73, 1110–1122 (2008)
N.G. Azios, S.F. Dharmawardhane, Neoplasia 7, 128–140 (2005)
J.M. Rey, P. Pujol, P. Callier et al., J. Mol. Endocrinol. 24, 433–440 (2000)
R. Strick, S. Ackermann, M. Langbein et al., J. Mol. Med. 85, 23–38 (2007)
E.R. Prossnitz, J.B. Arterburn, H.O. Smith et al., Annu. Rev. Physiol. 70, 165–190 (2008)
Acknowledgment
Work in this laboratory is supported by Australian NHMRC, University of Queensland. DF Wang is a recipient of postgraduate research scholarship from the Chinese Scholarship Council (CSC, China) and subsidy scholarship by the University of Queensland. Authors would like to acknowledge editorial help of M. Sinclair.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, D., Hu, L., Zhang, G. et al. G protein-coupled receptor 30 in tumor development. Endocr 38, 29–37 (2010). https://doi.org/10.1007/s12020-010-9363-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9363-z